                </a></li></ul></div><p><strong>Figure 8.  <span>Consequences of mutations within human TPI.</span></strong></p><a id="article1.body1.sec4.fig1.caption1.p1" name="article1.body1.sec4.fig1.caption1.p1"></a><p>Homozygous mutations within TPI affecting enzyme dimerization cause TPI deficiency, whereas homozygous mutations resulting in an inactive <em>TPI</em> allele are lethal.</p>
<a id="article1.body1.sec4.fig1.caption1.p2" name="article1.body1.sec4.fig1.caption1.p2"></a><p>Compound heterozygous individuals having inherited one inactive and one allele defective in dimerization properties will develop TPI deficiency, whereas heterozygote individuals having inherited a heterozygote null allele have an evolutionary advantage. (+: wild-type TPI; âˆ’: TPI with aberrant dimerization property; 0: allele encoding no or a catalytically inactive TPI).</p>
